Daily News Podcast

FDA approval for 2 HIV drugs


 

The FDA approves the once-daily oral drugs Delstrigo and Pifeltro for HIV-1 infection. Also today, emicizumab beats factor VIII prophylaxis by a wide margin, orodental issues are often associated with facial port-wine stains, and epilepsy often accompanies congenital Zika infections. Subscribe to the MDedge Daily News wherever you get your podcasts.
Amazon Alexa
Apple Podcasts
Spotify

Recommended Reading

When your patients are your neighbors
MDedge Pediatrics
Sleepio app tied to reducing insomnia, depression
MDedge Pediatrics
5 digital HIPAA myths
MDedge Pediatrics
Screen for cervical cancer based on age, risk
MDedge Pediatrics
Is it time for PCPs to take over chronic HCV?
MDedge Pediatrics
Rivaroxaban data abound at ESC 2018
MDedge Pediatrics
Children and teens are at risk for drug-drug interactions
MDedge Pediatrics
New MI definition for infarction vs injury
MDedge Pediatrics
Lorcaserin shows cardiovascular safety
MDedge Pediatrics
Lung function decline linked to cardiovascular risk
MDedge Pediatrics